This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Kostantine K Manouilov: Innovator in Pharmaceutical Prodrug Compositions
Introduction
Kostantine K Manouilov is a notable inventor based in Omaha, NE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrug compositions. His innovative work focuses on enhancing drug efficacy and delivery.
Latest Patents
Manouilov holds a patent for "Prodrug azide compositions and compounds." This patent describes pharmaceutical prodrug compositions that include azide derivatives of drugs, which can be converted to the active drug in vivo. The azide derivatives are designed to improve the half-life of the drugs and enhance their ability to penetrate the blood-brain barrier. This advancement is particularly beneficial for drugs such as cordycepin, 2′-F-ara-ddI, AraA, acyclovir, and penciclovir, among others.
Career Highlights
Throughout his career, Kostantine K Manouilov has focused on the intersection of chemistry and medicine. His work has led to the development of therapeutic compounds that address critical medical needs. With 1 patent to his name, he continues to push the boundaries of pharmaceutical innovation.
Collaborations
Manouilov has collaborated with esteemed colleagues in the field, including Jinfa Du and Raymond F Schinazi. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Kostantine K Manouilov is a pioneering inventor whose work in pharmaceutical prodrug compositions has the potential to transform drug delivery and efficacy. His contributions are vital to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile